Concepts (78)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Rheumatic Diseases | 3 | 2022 | 20 | 2.410 |
Why?
|
| Lupus Erythematosus, Systemic | 4 | 2022 | 206 | 1.960 |
Why?
|
| Sexual Health | 2 | 2022 | 14 | 1.650 |
Why?
|
| Reproductive Health | 3 | 2022 | 32 | 1.160 |
Why?
|
| Lupus Vasculitis, Central Nervous System | 1 | 2022 | 11 | 0.860 |
Why?
|
| Headache Disorders | 1 | 2022 | 6 | 0.860 |
Why?
|
| Pseudotumor Cerebri | 1 | 2022 | 16 | 0.860 |
Why?
|
| Sex Education | 1 | 2020 | 9 | 0.760 |
Why?
|
| Sexually Transmitted Diseases | 1 | 2022 | 91 | 0.750 |
Why?
|
| Health Education | 1 | 2020 | 101 | 0.720 |
Why?
|
| Pregnancy Complications, Hematologic | 1 | 2018 | 14 | 0.660 |
Why?
|
| Rheumatology | 3 | 2023 | 28 | 0.640 |
Why?
|
| Pregnancy Complications, Cardiovascular | 1 | 2018 | 104 | 0.620 |
Why?
|
| Bone Density | 1 | 2015 | 209 | 0.500 |
Why?
|
| Osteoporosis | 1 | 2015 | 121 | 0.490 |
Why?
|
| Child | 6 | 2022 | 6926 | 0.350 |
Why?
|
| Pregnancy | 3 | 2023 | 2894 | 0.260 |
Why?
|
| Age of Onset | 2 | 2021 | 310 | 0.230 |
Why?
|
| Pharmaceutical Services | 1 | 2022 | 9 | 0.220 |
Why?
|
| Sexual Behavior | 2 | 2022 | 302 | 0.220 |
Why?
|
| Adolescent | 4 | 2022 | 8979 | 0.210 |
Why?
|
| Parotitis | 1 | 2021 | 6 | 0.200 |
Why?
|
| Gender Identity | 1 | 2022 | 52 | 0.200 |
Why?
|
| Family Planning Services | 1 | 2022 | 36 | 0.200 |
Why?
|
| Sjogren's Syndrome | 1 | 2021 | 30 | 0.200 |
Why?
|
| Arthralgia | 1 | 2021 | 36 | 0.200 |
Why?
|
| Young Adult | 4 | 2022 | 5974 | 0.200 |
Why?
|
| Abortion, Induced | 1 | 2023 | 120 | 0.200 |
Why?
|
| Female | 8 | 2023 | 44509 | 0.190 |
Why?
|
| Contraception | 1 | 2022 | 88 | 0.190 |
Why?
|
| Transition to Adult Care | 1 | 2021 | 22 | 0.190 |
Why?
|
| Humans | 12 | 2023 | 86617 | 0.190 |
Why?
|
| Information Seeking Behavior | 1 | 2020 | 12 | 0.190 |
Why?
|
| Fever | 1 | 2020 | 125 | 0.180 |
Why?
|
| C-Reactive Protein | 1 | 2020 | 190 | 0.180 |
Why?
|
| Needs Assessment | 1 | 2020 | 154 | 0.170 |
Why?
|
| Atypical Hemolytic Uremic Syndrome | 1 | 2018 | 3 | 0.170 |
Why?
|
| Rheumatologists | 3 | 2023 | 6 | 0.170 |
Why?
|
| Thrombotic Microangiopathies | 1 | 2018 | 21 | 0.160 |
Why?
|
| Hypertension, Portal | 1 | 2018 | 47 | 0.160 |
Why?
|
| Portal Vein | 1 | 2018 | 120 | 0.160 |
Why?
|
| Parents | 1 | 2020 | 272 | 0.150 |
Why?
|
| Patient Education as Topic | 1 | 2020 | 351 | 0.150 |
Why?
|
| Pregnancy Outcome | 1 | 2018 | 247 | 0.140 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 316 | 0.130 |
Why?
|
| Venous Thrombosis | 1 | 2018 | 243 | 0.130 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2020 | 930 | 0.130 |
Why?
|
| Hypertension, Pulmonary | 1 | 2018 | 346 | 0.120 |
Why?
|
| Fractures, Bone | 1 | 2015 | 131 | 0.120 |
Why?
|
| Surveys and Questionnaires | 2 | 2023 | 2501 | 0.060 |
Why?
|
| Male | 3 | 2022 | 40958 | 0.060 |
Why?
|
| Adult | 2 | 2021 | 25640 | 0.060 |
Why?
|
| Focus Groups | 1 | 2022 | 155 | 0.050 |
Why?
|
| Mycophenolic Acid | 1 | 2022 | 87 | 0.050 |
Why?
|
| Hypergammaglobulinemia | 1 | 2021 | 8 | 0.050 |
Why?
|
| Xerostomia | 1 | 2021 | 10 | 0.050 |
Why?
|
| Dry Eye Syndromes | 1 | 2021 | 5 | 0.050 |
Why?
|
| Rheumatoid Factor | 1 | 2021 | 24 | 0.050 |
Why?
|
| Lymphopenia | 1 | 2021 | 28 | 0.050 |
Why?
|
| Antibodies, Antinuclear | 1 | 2021 | 83 | 0.050 |
Why?
|
| Receptors, Interleukin-6 | 1 | 2020 | 17 | 0.050 |
Why?
|
| Medication Adherence | 1 | 2022 | 129 | 0.050 |
Why?
|
| Neutropenia | 1 | 2021 | 215 | 0.050 |
Why?
|
| North America | 1 | 2021 | 180 | 0.050 |
Why?
|
| Thrombocytopenia | 1 | 2021 | 183 | 0.050 |
Why?
|
| Drug Monitoring | 1 | 2020 | 118 | 0.050 |
Why?
|
| Patient Transfer | 1 | 2021 | 91 | 0.050 |
Why?
|
| Cross-Sectional Studies | 1 | 2023 | 1621 | 0.040 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2020 | 339 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2020 | 1961 | 0.040 |
Why?
|
| Severity of Illness Index | 1 | 2020 | 1801 | 0.030 |
Why?
|
| Infant | 1 | 2021 | 3045 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2021 | 2767 | 0.030 |
Why?
|
| Child, Preschool | 1 | 2021 | 3611 | 0.030 |
Why?
|
| Time Factors | 1 | 2020 | 5209 | 0.030 |
Why?
|
| United States | 1 | 2021 | 6665 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2020 | 7990 | 0.020 |
Why?
|
| Aged | 1 | 2020 | 18402 | 0.010 |
Why?
|